MedTrace Logo

Use of Ketamine Prior to Cardiopulmonary Bypass in Children

NCT00556361 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2007-11-12

No results posted yet for this study

Summary

To assess whether the drug ketamine given prior to cardiopulmonary bypass can decrease injury to the cells in the brain.

Conditions

  • Ventricular Septal Defect

Interventions

DRUG

saline

2 mg/Kg IV saline within 5 minutes of initiation of Cardiopulmonary bypass

DRUG

ketamine

2 mg/Kg IV within 5 minutes of cardiopulmonary bypass

Sponsors & Collaborators

  • Arkansas Children's Hospital Research Institute

    lead OTHER

Principal Investigators

  • Adnan T Bhutta, MD · Arkansas Children's Hospital Research Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Max Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Completion
2007-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00556361 on ClinicalTrials.gov